Fellow of the Royal Society

Element Biosciences Establishes Scientific Advisory Board

Retrieved on: 
Monday, August 14, 2023
SAB, Stanford Cancer Institute, Fellow of the Royal Society, University, UCSB Physics Department, Stanford University, Medicine, Cancer research, Wellcome Sanger Institute, Eye, United States Air Force Scientific Advisory Board, RNA, Research, Genomics, Wolf Prize in Chemistry, Fellow of the Academy of Medical Sciences, Doctor of Philosophy, Associate, Biochemistry, Regenerative medicine, Molecular biology, Stanford University School of Medicine, EMBO, MD, SAN, Structural biology, Element, Biology, Science, SVP, Royal Society, Childhood cancer, Vaccine, Management, Pharmaceutical industry, Chemistry

SAN DIEGO, Aug. 14, 2023 /PRNewswire/ -- Element Biosciences, Inc., developer of the Element AVITI System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced the formation of its Scientific Advisory Board with four leading experts on genomics, oncology, chemistry, and biology.

Key Points: 
  • SAN DIEGO, Aug. 14, 2023 /PRNewswire/ -- Element Biosciences, Inc., developer of the Element AVITI System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced the formation of its Scientific Advisory Board with four leading experts on genomics, oncology, chemistry, and biology.
  • Element's Scientific Advisory Board will provide guidance and direction for research, development, and product innovation as the company continues its success and expansion in the genomics industry.
  • "With this diverse and accomplished group of scientists from across the globe, our Scientific Advisory Board empowers us to reach new heights in research and product innovation," said Michael Previte, PhD, Element CTO, SVP of R&D, and co-founder.
  • "I am thrilled to lead Element's Scientific Advisory Board," said Joseph (Jody) Puglisi, Jauch Professor in the Department of Structural Biology at Stanford University School of Medicine and Element's Scientific Advisory Board chair.

Meltwater acquires Oxford University spin-off, DeepReason.ai, to help build one of the largest knowledge graphs of public information

Retrieved on: 
Friday, November 19, 2021
Knowledge, CEO, University of Oxford, Technology, Software as a service, AI, Acquisition, Fellow of the Royal Society, Social analytics, Doctor of Philosophy, SAN, EPSRC, Royal Society, Meltwater, Research, GLOBE, Artificial intelligence, Social media, Efficiency, Intelligence, Management

SAN FRANCISCO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Meltwater B.V., a leading global SaaS provider of media intelligence and social analytics, has entered into a definitive agreement to acquire artificial intelligence start-up DeepReason.ai, a spin-off from Oxford University’s computer science department, for $7.3m in a combination of cash and Meltwater equity including earn-outs contingent on reaching technical milestones and retention requirements.

Key Points: 
  • This work represents 75 years of aggregate R&D experience, and is overseen by Georg Gottlob, Oxford professor and Fellow of the Royal Society.
  • Connected data, enriched with meaning, is foundational in getting answers to complex queries and deriving insights with more efficiency.
  • Every day, this knowledge graph expands by incorporating 2 billion connections to conversations around these companies, public personas and topics.
  • We are proud to join Meltwaters ambitious undertaking to build one of the worlds largest knowledge graphs of public information, said Dr. Stphane Reissfelder, CEO of DeepReason.ai.